Hepatitis a - PowerPoint PPT Presentation


Self-Testing & Self-Sampling Programme in Malaysia

The JOM.TEST Program in Malaysia offers fast, comforting, and confidential self-testing and self-sampling for vulnerable populations. It aims to combat stigma and discrimination and improve access to HIV, STIs, and hepatitis services.

2 views • 12 slides


Guidelines for Treating Chronic Hepatitis C Virus Infection

Clinical guidelines provide evidence-based recommendations for treating and curing chronic HCV infection in adults to improve treatment rates, reduce morbidity and mortality, and support the New York State Hepatitis C Elimination Plan. Recommendations include considerations in HCV treatment initiati

0 views • 28 slides



Epidemiology of hepatitis C in Ireland

Hepatitis C, a viral infection affecting the liver, has notable implications in Ireland, with key transmission routes, clinical manifestations, and long-term consequences shaping its epidemiology. From transmission patterns to chronic infection risks, understanding the natural history and prevalence

0 views • 24 slides


LiveRx Study - Eradicating Hepatitis C in Alberta

LiveRx Study aims to evaluate the impact of a collaborative program involving community pharmacies and organizations in treating HCV in Alberta. By leveraging pharmacist-led interventions, the initiative focuses on increasing HCV screening, diagnosis, and linkage to care, ultimately aiming to eradic

2 views • 13 slides


Implementing a Model to Combat the Syndemic at Cass Lake IHS

This presentation outlines the initiative to address the syndemic at Cass Lake IHS, focusing on Hepatitis C and harm reduction services. It discusses the background of Hepatitis C, the challenges faced in previous treatments, and the new pharmacist-run HCV clinic model. The aim is to educate on the

1 views • 35 slides


Understanding COVID-19's Impact on Joint Health: Reactive Arthritis vs Viral Arthritis

Explore the distinction between reactive arthritis and viral arthritis in the context of COVID-19, discussing symptoms, triggers, and potential long-term consequences on joint health. Learn how viral infections can lead to acute arthralgia and arthritis, including common pathogens such as Hepatitis

0 views • 30 slides


Meticulous Research® Predicts Vaccines Market to Reach $71.50 Billion by 2031

Vaccines Market Size, Share, Forecast, & Trends Analysis by Indication (Pneumococcal, Influenza, HPV, DTP, MMR, Hepatitis, COVID-19) Administration (IM, SC, Oral) Type (Inactivated, Combination) Valence (Multivalent, Monovalent) - Global Forecast to 2031\n

1 views • 5 slides


Diagnostic Specialty Antibodies Market is expected to grow at a CAGR of 4.6% fro

Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- For

0 views • 6 slides


Vaccines Market - A Comprehensive Analysis – 2024

Vaccines Market Size, Share, Forecast, & Trends Analysis by Indication (Pneumococcal, Influenza, HPV, DTP, MMR, Hepatitis, COVID-19) Administration (IM, SC, Oral) Type (Inactivated, Combination) Valence (Multivalent, Monovalent) - Global Forecast to

0 views • 4 slides


Understanding Cholestasis: Etiology, Clinical Manifestations, and Complications

Cholestasis is characterized by reduced bile flow and elevated direct bilirubin. It is critical to differentiate it from neonatal jaundice. In conditions like biliary atresia and 1-antitrypsin deficiency, early diagnosis and intervention are crucial to prevent liver failure. Clinical manifestations

5 views • 14 slides


Ethiopia's Initial Experience on Hepatitis B Birth Dose Pilot Implementation

Ethiopia's initial experience on Hepatitis B birth dose (HepB-BD) pilot implementation includes background statistics, HBsAg prevalence, hepatitis B vaccination coverage, distribution of HBV infection, existing guidelines/strategies, and activities prior to the start of HepB-BD piloting.

0 views • 17 slides


Understanding Amphistomosis in Ruminants: Causes, Symptoms, and Diagnosis

Amphistomosis is a disease in ruminants caused by several types of rumen flukes. It leads to productivity losses, weight loss, fertility reduction, and other symptoms. Infection occurs through ingestion of contaminated vegetables and raw meat. The parasite affects the rumen and reticulum of sheep, g

0 views • 8 slides


Bloodborne Pathogens Training Overview for Ground Team Members

Understanding bloodborne pathogens is crucial for ground team members to protect themselves and others. This training covers what bloodborne pathogens are, focusing on Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV), their symptoms, transmission risks, and prevention methods. HBV fact

0 views • 29 slides


Clinical Excellence in Hepatitis C Nursing: SCENS Program Overview

Demonstrating competency in infection control, abdominal assessment, specimen collection, and communication is crucial in nursing care for patients with Hepatitis C. The SCENS program focuses on key learning objectives to enhance clinical proficiency, address potential issues, and understand the com

0 views • 12 slides


Improving Hepatitis B Birth Dose Vaccination in Botswana

Hepatitis B vaccination coverage in Botswana faces challenges like poor documentation and premature infants not receiving the birth dose. Opportunities for improvement include enhancing data collection, evaluating the immunization program, and strengthening perinatal committees for quality care.

0 views • 9 slides


Understanding Water-borne Diseases and Pathogens

Drinking contaminated water can lead to water-borne diseases, causing millions of deaths annually, especially in developing countries. Potable water is essential for health and development, as water-related diseases arise from inadequate water quality and poor sanitation practices. Various pathogens

1 views • 28 slides


Hepatitis B Vaccines: Genuine vs Counterfeit - Insights from Uganda National Drug Authority

Explore the difference between genuine and counterfeit Hepatitis B vaccines in Uganda, as detailed by the National Drug Authority. Learn about the authorized vaccine on the market, counterfeit batch numbers, fake addresses on invoices/receipts, and the availability of vaccines in private sectors. St

0 views • 8 slides


Bloodborne Pathogens Training for Public Safety Officers & Sergeants

Bloodborne pathogens (BBPs) are pathogenic microorganisms found in human blood that can cause diseases like HIV, Hepatitis B, and Hepatitis C. Public safety officers and sergeants face occupational exposure to BBPs and should follow OSHA's BBP Standard to protect themselves. Training, vaccinations,

0 views • 41 slides


Immunization Requirements and Document Submission Guidelines

This information provides details on the immunization requirements, including the necessary vaccinations and titers for diseases such as Hepatitis B, MMR, Varicella (Chickenpox), Tdap, and Tuberculosis screening. It also outlines the steps for uploading documents, including lab reports, to comply wi

0 views • 18 slides


Understanding OSHA Bloodborne Pathogens Training and Hepatitis B Virus

Covering the basics of OSHA Bloodborne Pathogens Standard, this training material provides essential information on bloodborne pathogens, including Hepatitis B Virus (HBV). It emphasizes the importance of training for individuals with occupational exposure, outlining crucial topics such as Hepatitis

2 views • 56 slides


Canine Infectious Hepatitis (ICH) - Overview, Symptoms, and Treatment

Canine Infectious Hepatitis (ICH), also known as Rubarth's Disease, is caused by Canine Adenovirus-1 (CAdV-1), affecting dogs of all ages. The virus primarily targets hepatocytes, leading to acute hepatitis, as well as respiratory and ocular issues. Transmission occurs through contact with infected

6 views • 7 slides


Hepatitis B BD Introduction Plan in Ghana

In Ghana, the introduction plan for Hepatitis B BD involves evaluating disease burden, estimating seroprevalence among pregnant women, obtaining necessary approvals, presenting evidence to NITAG, and seeking support for introduction. A policy for screening and prevention is in place, aiming to addre

1 views • 10 slides


Introduction of Hepatitis B Birth Dose in Mozambique: A Step Towards Comprehensive Prevention

Mozambique is gearing up to introduce the Hepatitis B birth dose as a strategic approach in its immunization program, aiming to tackle the high prevalence of HBV within the population, particularly among women and HIV-positive individuals. The country's existing policies on screening pregnant women

0 views • 15 slides


Immunization Requirements for New BSN Students

Required immunization documentation, including Hepatitis B, MMR, Tetanus, Varicella, and Influenza, must be submitted before enrolling in Nursing classes. A titer is a blood test measuring immunity to diseases. Details on Hepatitis B vaccination series, MMR requirements, and non-responder status are

0 views • 13 slides


National Viral Hepatitis Control Program - Achieving Universal Health Coverage and Elimination Goals

The National Viral Hepatitis Control Program in India is working towards combating viral hepatitis and achieving SDG goal 3.3 through a comprehensive approach that includes awareness generation, prevention, management, and financing under the NHM. The aim is to eliminate hepatitis C by 2030, reduce

0 views • 19 slides


Diagnostic Specialty Antibodies Market, Diagnostic Antibody, Infectious Disease

Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- For

0 views • 3 slides


Blood-Borne Disease Hazards in Healthcare Settings

Healthcare workers face risks of exposure to bloodborne pathogens like HIV, HBV, and HCV. This training module covers sources and routes of exposure, emphasizing the importance of universal precautions. Specific focus is given to Hepatitis B and C viruses, their impact on the liver, transmission met

0 views • 30 slides


Healthcare Laws and Regulations Quizzes

This content provides quizzes related to healthcare laws, regulations, and best practices. Topics include reporting communicable diseases, control measures for occupational exposure, handling dermatitis in healthcare settings, definitions of healthcare organizations, and OSHA requirements for Hepati

2 views • 42 slides


Diagnostic Specialty Antibodies Market: Opportunities in Developing Regions

Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- For

0 views • 3 slides


Understanding Water Hygiene and its Health Implications

Proper water hygiene is crucial in preventing the spread of water-borne diseases like cholera, typhoid, and hepatitis. Regular testing and treatment methods such as boiling or chlorination help ensure safe water for healthcare settings. Insufficient water quality can lead to various illnesses, empha

0 views • 32 slides


Advances in Hepatitis C Treatment for HIV-Infected Patients: A Comprehensive Overview

Explore the latest advancements in the treatment of Hepatitis C virus (HCV) in HIV-infected individuals through a detailed presentation by Dr. Kara W. Chew. Learn about the initial evaluation for HCV, treatment options for different genotypes, management of advanced fibrosis, recommended approaches

0 views • 9 slides


Bloodborne Pathogens Exposure: HIV Post Exposure Prophylaxis Regimen

Take immediate action for exposure to bloodborne pathogens like HIV and Hepatitis C through a post-exposure prophylaxis (PEP) regimen. Administer PEP within 48 hours for increased-risk exposures like needle sticks or contact with infected fluids. Coordinate evacuation if needed and conduct Rapid Dia

0 views • 5 slides


Addressing Health Disparities in Prisons: Module 6 Overview

People in prisons face higher rates of HIV, viral hepatitis, STIs, and TB but often lack access to quality healthcare. Module 6 focuses on promoting health and human rights in closed settings, drawing on UN guidance. Framing questions challenge misconceptions about healthcare and prevention services

0 views • 26 slides


Nottingham University Hospitals NHS Trust - Hepatology Services Overview

Nottingham University Hospitals NHS Trust offers comprehensive Hepatology services at the Queen's Medical Centre, with a specialized team providing inpatient and outpatient care, liver transplants, viral hepatitis treatment, and advanced HPB endoscopy. The department is highly research-active and of

0 views • 10 slides


Elimination of Hepatitis C in Individuals With HIV Infection

Discussing the goals, treatment options, and global impact of Hepatitis C in individuals with HIV infection, this presentation by Dr. David L. Thomas from Johns Hopkins Medical Institutions sheds light on important aspects such as mortality projections, WHO elimination goals, and targets for hepatit

0 views • 40 slides


Decline of Hepatitis C in England: 2022 Report Highlights

The 2022 report on Hepatitis C in England shows a continued decline in the prevalence of chronic HCV infection, with around 81,000 individuals estimated to be affected in 2020. The report also highlights the distribution of infections among individuals with different drug injecting histories. Data f

0 views • 41 slides


Hepatitis C Screening Recommendations for Adults (2017)

The Canadian Task Force on Preventive Health Care (CTFPHC) released recommendations on Hepatitis C screening for adults in 2017. The guidelines provide an overview of screening methods, key findings, implementation considerations, and conclusions. Those at higher risk for HCV in Canada include indiv

0 views • 38 slides


Understanding Zoonotic Hepatitis A Virus Infections

Zoonotic hepatitis A virus infections primarily affect humans and nonhuman primates, with transmission occurring through fecal-oral route. This article delves into the reservoir, mode of transmission, clinical signs, and diagnosis of hepatitis A, shedding light on its impact on both species. Nonhuma

0 views • 22 slides


Epidemiology of Hepatitis B and C in Florida: 2019 Data Analysis

The Department of Health in Florida has released the 2019 data on the epidemiology of Hepatitis B and C as of January 21, 2021. The report includes information on acute and chronic cases, technical notes on case definitions, and changes in national case definitions in 2020. Acute cases require speci

0 views • 35 slides


Understanding Viral Hepatitis: Causes, Types, and Clinical Symptoms

Viral hepatitis is caused by various hepatotropic viruses, including Hepatitis A, B, C, D, and E. This type of liver inflammation can manifest acutely or chronically, leading to symptoms such as jaundice, abdominal pain, nausea, and fatigue. Hepatitis A virus, in particular, is primarily transmitted

0 views • 36 slides